Case Studies

Browse the Full Library or Filter Cases Below

FILTER CONTENT
Sort By:
oncotype-dx-colon-recurrence-score

oncotype-dx-breast-dcis-score

oncotype-dx-breast-recurrence-score

  • Age
  • Gender
  • Histologic Grade
  • Lymph Node Status
  • # of Lymph Nodes Assessed
  • Lymphovascular invasion (LVI)
  • MMR Status
  • Obstruction
  • Perforation
  • Recurrence Score
  • Tumor Stage

RESET FILTERS

Results

74-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 37

55-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 19

54-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 27

72-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 33

46-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 39

48-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 15

65-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 25

74-Year-Old Female Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 16

53-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 42

67-Year-Old Female Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 13

85-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 24

74-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 35

65-Year-Old Male Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 26

52-Year-Old Female Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 0

91-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 25

57-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 41

45-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 22

54-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 39

61-Year-Old Female Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 13

73-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 19

82-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 42

65-Year-Old Male Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 30

61-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 31

54-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 30

67-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 16

68-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 22

62-Year-Old Female Patient | 

with Stage III A/B Tumor


Recurrence Score® result: 12

87-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 38

71-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 11

42-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 37

47-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 13

41-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 26

55-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 18

59-Year-Old Male Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 43

72-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 33

72-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 25

86-Year-Old Female Patient | 

with Stage II T3 Tumor


Recurrence Score® result: 32

Interesting Colon Cancer Case?

Use our case studies submission form to quickly and easily share interesting cases on OncotypeIQ.com.

Share a Case

Stay in Touch

Have questions? We're here to help.

 Contact Us
Copyright © 2004- Genomic Health, Inc. All Rights Reserved.
In the US and certain other jurisdictions, Genomic Health, Oncotype, Oncotype DX, Oncotype IQ, Oncotype MAP, Breast Recurrence Score, Recurrence Score, DCIS Score, Colon Recurrence Score, Genomic Prostate Score, GPS, AR-V7 Nucleus Detect, Pass It On: Until Every Woman Knows, and Making Cancer Care Smarter are trademarks of Genomic Health, Inc. Exact Sciences is a trademark of Exact Sciences Corporation.
Making cancer care smarter.®